Home  >  News
Eppen_Research3neo_Feb26
you can get e-magazine links on WhatsApp. Click here
News
  Novo Medi Sciences launches Nexipox Plus, a next-generation varicella vaccine built on advanced formulation,   January 24, 2026
  Entod unveils losartan eye drops to redefine the future of corneal healing and vision restoration,   January 15, 2026
  Alkem launches Renocia cyclical therapy to support hair growth,   January 08, 2026
  Dr Reddy's launches Hevaxin, a novel recombinant hepatitis E vaccine in India,   January 07, 2026
  Novo Nordisk announces launch of Ozempic in India,   December 12, 2025
  Zydus introduces biosimilar denosumab 120 mg SC – protecting bone health in cancer patients,   December 10, 2025
  Emcutix Biopharma introduces SOLGLO-AZ liposomal serum for hyperpigmentation in India,   December 09, 2025
  Botanic Healthcare launches CornFit, a patented cornsilk-based nutraceutical extract for metabolic health,   December 09, 2025
  Entod unveils long term solution for nasal dryness with hydration spray, Lubrinase,   November 12, 2025
  Emcutix Biopharma unveils AquaOat with’s unique technological innovation,   November 06, 2025
  Bristol Myers Squibb launches Kopozgo in India for the treatment of symptomatic oHCM,   October 14, 2025
  Medical Cannabis wellness startup Awshad launches 6500 mg CBD oil for chronic pain,   October 06, 2025
  750AD Healthcare unveils five new product divisions: Levitate, Bamwoodo, La Ravaya, Health Bull, and Solbacca,   September 08, 2025
  Glenmark to launch Micafungin for injection USP, 50 mg/vial and 100 mg/vial,   August 19, 2025
  Alkem launches Olesoft Trucera, an advanced ceramide-boosting moisturizing lotion for skin barrier repair,   August 19, 2025
  Torrent Pharma extends Shelcal brand into the adult nutrition powder segment,   July 24, 2025
  Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer,   June 24, 2025
  Amway India strengthens its immunity portfolio; launches Nutrilite Triple Protect,   June 17, 2025
  Glenmark Pharma to launch DCGI-approved Brukinsa in India to advance treatment of haematological malignancies,   June 09, 2025
  Servier India introduces ‘Ivosidenib’ in India, first-in-class targeted therapy in oncology for rare IDH1-mutated AML & CCA,   June 06, 2025

 Back
 
ChemExpo_India_2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram